American Oncology Partners PA Center for Cancer and Blood Disorders

Bethesda, Maryland 20817

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Hormone-sensitive Prostate Cancer, Relapsing Multiple Sclerosis

Studies at this site

• An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) — Recruiting now
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling